Authors:
WETZLER M
BERNSTEIN SH
BAUMANN H
FRIES KM
STEWART C
BLUMENSON L
BAER MR
HERZIG GP
BLOOMFIELD CD
SLACK JL
Citation: M. Wetzler et al., EXPRESSION AND FUNCTION OF THE MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR-RECEPTOR IN ACUTE MYELOID-LEUKEMIA BLASTS, Leukemia & lymphoma, 30(5-6), 1998, pp. 415
Authors:
XIA Z
BAER MR
BLOCK AMW
BAUMANN H
WETZLER M
Citation: Z. Xia et al., EXPRESSION OF SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION PROTEINS IN ACUTE MYELOID-LEUKEMIA BLASTS, Cancer research, 58(14), 1998, pp. 3173-3180
Authors:
SHAH M
JENIS EH
MOOKERJEE BK
SCHRIBER JR
BAER MR
HERZIG GP
WETZLER M
Citation: M. Shah et al., INTERFERON-ALPHA-ASSOCIATED FOCAL SEGMENTAL GLOMERULOSCLEROSIS WITH MASSIVE PROTEINURIA IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA FOLLOWINGHIGH-DOSE CHEMOTHERAPY, Cancer, 83(9), 1998, pp. 1938-1946
Authors:
GISSLINGER H
KURZROCK R
WETZLER M
TUCKER S
KANTARJIAN H
ROBERTSON B
TALPAZ M
Citation: H. Gisslinger et al., APOPTOSIS IN CHRONIC MYELOGENOUS LEUKEMIA - STUDIES OF STAGE-SPECIFICDIFFERENCES, Leukemia & lymphoma, 25(1-2), 1997, pp. 121
Authors:
WETZLER M
BAER MR
BERNSTEIN SH
BLUMENSON L
STEWART C
BARCOS M
MROZEK K
BLOCK AMW
HERZIG GP
BLOOMFIELD CD
Citation: M. Wetzler et al., EXPRESSION OF C-MPL MESSENGER-RNA, THE RECEPTOR FOR THROMBOPOIETIN, IN ACUTE MYELOID-LEUKEMIA BLASTS IDENTIFIES A GROUP OF PATIENTS WITH POOR RESPONSE TO INTENSIVE CHEMOTHERAPY, Journal of clinical oncology, 15(6), 1997, pp. 2262-2268
Authors:
WETZLER M
KURZROCK R
ESTROV Z
BARONE S
ESTEY E
TALPAZ M
Citation: M. Wetzler et al., SUPPRESSED FORMATION OF BONE-MARROW ADHERENT LAYERS DERIVED FROM ACUTE MYELOID-LEUKEMIA PATIENTS AFTER IN-VITRO EXPOSURE TO INTERLEUKIN-4, Leukemia research, 21(6), 1997, pp. 519-527
Authors:
XIA Z
BAER MR
BLOCK AW
BAUMANN H
WETZLER M
Citation: Z. Xia et al., CONSTITUTIVE ACTIVATION OF SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION PROTEINS (STATS) AND PROTEIN-TYROSINE KINASE (PTK) IN ACUTE MYELOID-LEUKEMIA (AML) BLASTS - NOVEL PATHWAYS FOR LEUKEMOGENESIS, Blood, 90(10), 1997, pp. 3617-3617
Authors:
ALAM A
BAER MR
BERNSTEIN S
BERNSTEIN Z
CHRISTIANSEN N
CZUCZMAN M
SCHRIBER J
SLACK J
TEZCAN H
WETZLER M
COOPER M
MILK B
FORD L
HERZIG G
MCCARTHY P
Citation: A. Alam et al., PHASE-II CLINICAL-TRIAL OF OKT3 FOR ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD) PROPHYLAXIS IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLOBMT), Blood, 90(10), 1997, pp. 449-449
Authors:
ALIDINA A
BAER R
BERNSTEIN S
BERNSTEIN Z
CHRISTIANSEN N
CZUCZMAN M
SCHRIBER J
SLACK J
SPANGENTHAL T
TEZCAN H
WETZLER M
MILK B
SWINNICH D
FORD L
HERZIG G
MCCARTHY P
Citation: A. Alidina et al., THIOTEPA-ASSOCIATED CARDIOMYOPATHY DURING HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Blood, 90(10), 1997, pp. 984-984
Authors:
SCHRIBER JR
BAER MR
CHRISTIANSEN NP
MCCARTHY PL
SLACK JL
TEZCAN H
WETZLER M
HERZIG GP
Citation: Jr. Schriber et al., MURINE MONOCLONAL-ANTIBODY DIRECTED AGAINST CD3 (OKT3) IS AN EFFECTIVE TREATMENT FOR MODERATE (GRADE-II) BUT NOT FOR SEVERE (GRADE-III OR GRADE-IV) STEROID-RESISTANT GRAFT-VERSUS-HOST DISEASE (GVHD), Blood, 88(10), 1996, pp. 3786-3786
Authors:
BAUMANN H
KUROPATWINSKI KK
WANG Y
KIM H
KORDULA T
RIPPERGER J
FEY GH
VANETTEN RA
WETZLER M
Citation: H. Baumann et al., BCR ABL KINASES MIMIC HEMATOPOIETIN RECEPTORS BY ACTIVATING COMMON SETS OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION (STAT) PROTEINSAND INDUCING GENE-EXPRESSION THROUGH CYTOKINE-RESPONSIVE ELEMENTS/, Blood, 88(10), 1996, pp. 804-804
Authors:
SCHRIBER JR
MILK BJ
BAER MR
CHRISTIANSEN NP
MCCARTHY PL
SLACK JL
TEZCAN H
WETZLER M
HERZIG GP
Citation: Jr. Schriber et al., A RANDOMIZED PHASE-II TRIAL COMPARING HEPARIN (HEP)+ -PROSTAGLANDIN-E1 (PG) TO PREVENT HEPATOTOXICTY (HT) FOLLOWING BONE-MARROW TRANSPLANTATION (BMT) - PRELIMINARY-RESULTS/, Blood, 88(10), 1996, pp. 1642-1642
Authors:
WETZLER M
BAER MR
BERNSTEIN SH
BLUMENSON L
STEWART C
BARCOS M
MROZEK K
BLOCK AMW
HERZIG GP
BLOOMFIELD CD
Citation: M. Wetzler et al., EXPRESSION OF MESSENGER-RNA ENCODING C-MPL, THE RECEPTOR FOR THROMBOPOIETIN, IN ACUTE MYELOID-LEUKEMIA (AML) BLASTS IDENTIFIES A GROUP OF PATIENTS (PTS) WITH POOR OUTCOME TO INTENSIVE CHEMOTHERAPY, Blood, 88(10), 1996, pp. 2526-2526
Citation: R. Kurzrock et al., INTERLEUKIN-1 AND ITS INHIBITORS - A BIOLOGIC AND THERAPEUTIC MODEL FOR THE ROLE OF GROWTH-REGULATORY FACTORS IN LEUKEMIAS, Cytokines and molecular therapy, 1(3), 1995, pp. 177-184
Authors:
SEYMOUR JF
TALPAZ M
CABANILLAS F
WETZLER M
KURZROCK R
Citation: Jf. Seymour et al., SERUM INTERLEUKIN-4 LEVELS CORRELATE WITH PROGNOSIS IN DIFFUSE LARGE-CELL LYMPHOMA, Journal of clinical oncology, 13(3), 1995, pp. 575-582
Authors:
WETZLER M
KURZROCK R
ESTROV Z
ESTEY E
TALPAZ M
Citation: M. Wetzler et al., CYTOKINE EXPRESSION IN ADHERENT LAYERS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROME AND ACUTE MYELOGENOUS LEUKEMIA, Leukemia research, 19(1), 1995, pp. 23-34
Authors:
WETZLER M
TALPAZ M
YEE G
STASS SA
VANETTEN RA
ANDREEFF M
GOODACRE AM
KLEINE HD
MAHADEVIA RK
KURZROCK R
Citation: M. Wetzler et al., CELL CYCLE-RELATED SHIFTS IN SUBCELLULAR-LOCALIZATION OF BCR - ASSOCIATION WITH MITOTIC CHROMOSOMES AND WITH HETEROCHROMATIN, Proceedings of the National Academy of Sciences of the United Statesof America, 92(8), 1995, pp. 3488-3492
Authors:
BERNSTEIN SH
BAER MR
LAWRENCE D
HERZIG GP
BLOOMFIELD CD
WETZLER M
Citation: Sh. Bernstein et al., SERIAL DETERMINATION OF THROMBOPOIETIN (TPO), IL-3, IL-6, IL-11 AND LEUKEMIA INHIBITORY FACTOR (LIF) LEVELS IN PATIENTS UNDERGOING CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA (AML), Blood, 86(10), 1995, pp. 170-170
Authors:
SCHRIBER J
CHRISTIANSEN N
BAER MR
SLACK J
WETZLER M
HERZIG G
Citation: J. Schriber et al., TISSUE-PLASMINOGEN ACTIVATOR (TPA) AS THERAPY FOR HEPATOTOXICITY FOLLOWING BONE-MARROW TRANSPLANTATION, Blood, 86(10), 1995, pp. 869-869
Authors:
SCHRIBER J
CHRISTIANSEN N
BAER MR
STACK J
WETZLER M
HERZIG G
Citation: J. Schriber et al., HIGH-DOSE THIOTEPA AND CAREOPLANTINUM PREPARATIVE REGIMEN FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION (BMT) - A PHASE I-II STUDY, Blood, 86(10), 1995, pp. 3845-3845
Authors:
FERRAJOLI A
TALPAZ M
ORDONEZ NG
STANLEY ER
HIRSCHGINSBERG C
ZIPF TF
WETZLER M
KURZROCK R
ESTROV Z
Citation: A. Ferrajoli et al., INTERLEUKIN-4 ALTERS HUMAN BONE-MARROW STROMA AND MODULATES ITS INTERACTION WITH HEMATOPOIETIC PROGENITORS, Stem cells, 12(6), 1994, pp. 638-649